达菲市场：按药物类型、配方、适应症（甲型流感、乙型流感、猪流感）、分销渠道、地区-规模、份额、展望、机会分析，2022-2030 年

磷酸奥司他韦适用于甲型流感、乙型流感等。 它可以减轻流感病毒引起的症状，例如鼻塞、咳嗽、喉咙痛、发烧/发冷、疼痛和不适。 此外，该药物可将恢復时间缩短 1 至 2 天。 如果您与其他流感患者有过接触，或者您所在地区正在流行流感，则该药物也可用于预防流感。 该药物的作用机制是阻止流感病毒繁殖。 应按照医生规定的适当时间间隔服用药物。 如果提前停药，可能会导致病毒繁殖和感染復发。

市场动态

美国不断上升的流感发病率预计将在预测期内推动全球达菲（磷酸奥司他韦）市场的增长。 例如，根据发表在《柳叶刀》杂誌上的一篇论文，到 2022 年，症状性流感的年发病率估计为 3-11%。 美国国家免疫和呼吸系统疾病中心的研究人员进行的多项研究表明，儿童最容易感染流感病毒并患病，而且发病率随着年龄的增长而降低。

达菲（磷酸奥司他韦）的投放量预计会增加，从而在预测期内推动全球达菲（磷酸奥司他韦）的增长。 例如，2018 年，印度製药公司 Natco Pharma 及其营销合作伙伴美国製药公司 Alvogen 在美国推出了第一个仿製药 Tamiflu（磷酸奥司他韦）。

这项研究的主要特点

• 本报告对全球达菲（磷酸奥司他韦）市场进行了深入分析，显示了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。优惠。
• 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
• 它还提供重要的见解，例如市场促进因素、抑制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争战略。
• 它根据以下参数介绍了全球达菲（磷酸奥司他韦）市场的主要参与者 - 公司亮点、产品组合、主要亮点、财务业绩、本研究涵盖的战略 F.Hoffmann-La Roche Ltd. 、NATCO Pharma Limited、Tea Pharmaceutical Industries Ltd.、LUPINE Limited、Amneal Pharmaceuticals LLC、Zydus Cadila、Sun Pharmaceutical Industries Ltd.、Alembic Pharmaceuticals Limited、Mylan N.V. 和 Hetero Group。
• 这份报告中的见解将使企业营销人员和管理人员能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 本研究报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球达菲（磷酸奥司他韦）市场的各种战略矩阵来促进他们的决策。

目次

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第 2 章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按药物类型
  • 市场概况：按剂型分类
  • 市场概况：按指示
  • 市场概况：按分销渠道
  • 市场概况：按地区
• 连贯机会图 (COM)

第 3 章市场动态、规律及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 市场吸引力分析
  • 市场机会
• 产品公告
• 市场趋势
• 合併、收购、联合研究
• 监管准则和合规性
• 主要发展状况
• 害虫分析
• 技术
• 定价分析 (2021)

第 4 章达菲（磷酸奥司他韦）的全球市场 - 冠状病毒 (COVID-19) 大流行的影响

• 经济影响
• COVID-19 的流行病学特征
• 对供需的影响

第 5 章按药物类型分列的全球达菲（磷酸奥司他韦）市场，2017-2030

• 品牌名称
• 仿製药

第 6 章全球达菲（磷酸奥司他韦）市场的配方：2017-2030

• 胶囊
• 暂停

第 7 章达菲（磷酸奥司他韦）的全球市场达菲（磷酸奥司他韦）的全球市场：按适应症分类，2017-2030 年（百万美元

• 甲型流感
• 乙型流感
• 猪流感（甲型 H1N1 流感）

第 8 章达菲（磷酸奥司他韦）全球市场：按分销渠道，2017-2030 年

• 医院药房
• 零售药房
• 在线药店

第 9 章按地区分列的全球达菲（磷酸奥司他韦）市场，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第 10 章竞争格局

• F.Hoffmann-La Roche Ltd.
• NATCO Pharma Limited
• Teva Pharmaceutical Industries Ltd.
• LUPIN Limited
• Amneal Pharmaceuticals LLC
• Zydus Cadila
• Sun Pharmaceutical Industries Ltd.
• Alembic Pharmaceuticals Limited
• Mylan N.V
• Hetero Group

第 11 章章节

• 调查方法
• 关于出版商

Oseltamivir phosphate is indicated for the treatment of influenza A, influenza B, and Others. It reduces the symptoms caused by influenza virus such as stuffy nose, cough, sore throat, fever/chills, aches, and tiredness. Moreover, the medicine reduces the recovery time by 1-2 days. This medication may also be used to prevent the flu if the person is exposed to other patient who already is suffering from flu or if there is a flu pandemic in the community. The mode of action for the treatment is that, this medication works by stopping the flu virus from growing. The medicine should be taken at the proper time interval as prescribed by the doctor. If the intake of medicine is terminated at an early stage then, this may lead to the growth of the virus, which may relapse of the infection.

Market Dynamics

Increasing incidence of influenza among the U.S. population is expected to increase the growth of the global Tamiflu (oseltamivir phosphate) market over the forecast period. For instance, according to the article published in the Lancet journal, 2022, the annual incidence of symptomatic influenza is estimated to vary from 3 to 11%. According to the various studies carried out by the researchers in National Center for Immunization and Respiratory Diseases, U.S., it was found that, influenza virus infections and illness rates are highest in children and the rate of illness decrease with the increasing age.

Increasing launches of Tamiflu (oseltamivir phosphate) is expected to drive the growth of the global Tamiflu (oseltamivir phosphate) over the forecast period. For instance, in 2018, Natco Pharma, Indian pharmaceutical company and their marketing partner Alvogen, U.S. based pharmaceutical company launched, the first generic version of Tamiflu (oseltamivir phosphate) in the U.S.

Key features of the study:

• This report provides in-depth analysis of the global Tamiflu (oseltamivir phosphate) market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Tamiflu (oseltamivir phosphate) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include F.Hoffmann-La Roche Ltd., NATCO Pharma Limited, Tea Pharmaceutical Industries Ltd., LUPIN Limited, Amneal Pharmaceuticals LLC, Zydus Cadila, Sun Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, Mylan N.V., and Hetero Group.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Tamiflu (oseltamivir phosphate) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Tamiflu (oseltamivir phosphate) market

Detailed Segmentation:

• Global Tamiflu (Oseltamivir Phosphate) Market, By Drug Type:
  • Branded
  • Generic
• Global Tamiflu (Oseltamivir Phosphate) Market, By Dosage Form:
  • Capsules
  • Suspension
• Global Tamiflu (Oseltamivir Phosphate) Market By Indication:
  • Influenza A
  • Influenza B
  • Swine Flu (H1N1 Influenza A)
• Global Tamiflu (Oseltamivir Phosphate) Market By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Tamiflu (Oseltamivir Phosphate) Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • F. Hoffmann-La Roche Ltd.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NATCO Pharma Limited
  • Teva Pharmaceutical Industries Ltd.
  • LUPIN Limited
  • Amneal Pharmaceuticals LLC
  • Zydus Cadila
  • Sun Pharmaceutical Industries Ltd.
  • Alembic Pharmaceuticals Limited
  • Mylan N.V.
  • Hetero Group

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Type
  • Market Snapshot, By Dosage Form
  • Market Snapshot, By Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Market Trends
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis
• Technology Landscape
• Pricing Analysis (2021)

4. Global Tamiflu (Oseltamivir Phosphate) Market - Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Tamiflu (Oseltamivir Phosphate) Market, By Drug Type, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Branded
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Generic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Tamiflu (Oseltamivir Phosphate) Market, By Dosage Form, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Capsules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Suspension
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Tamiflu (Oseltamivir Phosphate) Market, By Indication, 2017 - 2030, (US$ Million

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Influenza A
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Influenza B
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Swine Flu (H1N1 Influenza A)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Tamiflu (Oseltamivir Phosphate) Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Tamiflu (Oseltamivir Phosphate) Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• F.Hoffmann-La Roche Ltd.*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NATCO Pharma Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LUPIN Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Amneal Pharmaceuticals LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zydus Cadila
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Alembic Pharmaceuticals Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mylan N.V
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Hetero Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

11. Section

• Research Methodology
• About Us